[Results with the combination of nitrofurantoin (macrocristalline) and sulphadiazine in chronic urinary tract infections (author's transl)].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003556:Cystitis / Q000150:complications; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000150:complications; D013411:Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
D004338:Drug Combinations; D013411:Sulfadiazine; D009582:Nitrofurantoin
Erfahrungen mit der Kombination von Nitrofurantoin (makrokristallin) und Sulfadiazin bei chronischen Harnwegsinfektionen